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Background: Recently, we determined that in a rigorously monitored environment an intensive diet-induced
weight loss of 10% combined with exercise was significantly more effective at reducing pain in men and women
with symptomatic knee osteoarthritis (OA) than either intervention alone. Compared to previous long-term weight
loss and exercise trials of knee OA, our intensive diet-induced weight loss and exercise intervention was twice as
effective at reducing pain intensity. Whether these results can be generalized to less intensively monitored cohorts
is unknown. Thus, the policy relevant and clinically important question is: Can we adapt this successful solution to a
pervasive public health problem in real-world clinical and community settings? This study aims to develop a systematic,
practical, cost-effective diet-induced weight loss and exercise intervention implemented in community settings and to
determine its effectiveness in reducing pain and improving other clinical outcomes in persons with knee OA.
Methods/Design: This is a Phase III, pragmatic, assessor-blinded, randomized controlled trial. Participants will include
820 ambulatory, community-dwelling, overweight and obese (BMI≥ 27 kg/m2) men and women aged≥ 50 years who
meet the American College of Rheumatology clinical criteria for knee OA. The primary aim is to determine whether a
community-based 18-month diet-induced weight loss and exercise intervention based on social cognitive theory and
implemented in three North Carolina counties with diverse residential (from urban to rural) and socioeconomic
composition significantly decreases knee pain in overweight and obese adults with knee OA relative to a nutrition and
health attention control group. Secondary aims will determine whether this intervention improves self-reported function,
health-related quality of life, mobility, and is cost-effective.
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Discussion: Many physicians who treat people with knee OA have no practical means to implement weight loss and
exercise treatments as recommended by numerous OA treatment guidelines. This study will establish the effectiveness of
a community program that will serve as a blueprint and exemplar for clinicians and public health officials in urban and
rural communities to implement a diet-induced weight loss and exercise program designed to reduce knee pain and
improve other clinical outcomes in overweight and obese adults with knee OA.
Trial registration: clinicaltrials.gov Identifier: NCT02577549 October 12, 2015.
Keywords: Osteoarthritis, Knee pain, Clinical trial, Pragmatic, Community based researchBackground
Worldwide, only half of the population seeking osteoarth-
ritis (OA) health management receive appropriate care.
This is due, in part, to limited prescription of non-
pharmacologic interventions, the rise of pharmacologic pre-
scriptions for symptom management, low patient health
literacy, and barriers impeding lifestyle modifications [1, 2].
Knee OA is the most common and persistent cause of mo-
bility dependency and disability; its prevalence is estimated
at over 250 million, or 3.6% of the world’s population [3, 4].
OA is chronic – patients live with the symptoms for an
average of 26 years [5]. With no effective disease-modifying
interventions, treatment focuses on pain relief, but the
safety concerns associated with many pain medications
highlight the need for safe, effective non-pharmacologic in-
terventions. Clinical guidelines strongly encourage the use
of non-pharmacologic exercise and diet to relieve pain and
improve function [6, 7]. Unfortunately, only 25% of the pa-
tients requiring advice concerning these treatments (BMI ≥
27 kg/m2 with diagnosed knee OA) receive the necessary
care [8]. Moreover, these interventions, proven effective
under highly controlled conditions, have yet to show long-
term improvements in community settings [9–11].
The association between obesity and knee OA was
first documented in 1945 and has been widely verified
[12–15]. Two in three obese people may develop symp-
tomatic knee OA in their lifetime [16]. Obesity is the
most modifiable risk factor for knee OA, and weight loss
is a safe, effective non-pharmacologic intervention to
improve clinical outcomes [9, 10]. Recently, our Inten-
sive Diet and Exercise for Arthritis (IDEA) trial com-
pared a diet-induced weight-loss (D) of 10% of baseline
weight and exercise (E) interventions, separately and in
combination (D + E), across an 18-month period in 454
overweight and obese older adults with knee OA. The
primary mechanistic outcomes, knee joint loads and in-
flammation, were reduced in D and D + E compared to
E [10]. An intent-to-treat analysis also revealed that
while D and E successfully reduced pain after 18 months
(D: 25%, E: 28%), the combination of D + E was twice as
effective with a 51% decrease from baseline. The D + E
group was also superior to the E group on other clinicalmeasures including physical function and walking speed.
IDEA, with its 10% weight loss, produced superior re-
sults to our previous trial (ADAPT) of exercise and 5%
weight loss that resulted in a 30% reduction in pain [9].
Taken together, these trials provide strong support for
our model (Fig. 1) indicating that weight loss plus exer-
cise improves clinical outcomes by affecting both the
biomechanical and inflammatory OA disease pathways,
decreasing knee joint loads and pro-inflammatory cyto-
kine activity.
IDEA was an efficacy study implemented in a university
setting under rigorously monitored conditions that in-
cluded highly educated and well trained staff, and excellent,
well-maintained facilities. Clinicians have expressed con-
cern about the lack of practical means to implement and
sustain a similar program in a community-based environ-
ment. Thus, determining whether we can adapt this suc-
cessful program to a pervasive public health problem in
real-world clinical and community settings is a clinically
important question that has public policy implications.
Approximately 25% of the United States population lives
in rural communities [17–19] with most having fewer ser-
vices and resources than urban communities [20]. Rural
dwellers report poorer health-related quality of life [21],
reflecting higher prevalence of many disorders, including
knee OA. Delivering proven health interventions to com-
munities with limited healthcare access is a national public
health priority [22]. Weight-loss and Exercise for Commu-
nities with Arthritis in North Carolina (we-can) is the first
long-term trial of diet-induced weight loss and exercise in
older adults with knee OA implemented under pragmatic
conditions in both rural and urban communities. Building
on the results of IDEA, the intent of the we-can trial is to
translate this highly beneficial, long-term intervention for
a major chronic health condition to diverse community
settings.
Few trials are purely pragmatic; most fall on a continuum
between pragmatism and efficacy [23]. The pragmatic com-
ponents of we-can include: (1) large sample size (N = 820);
(2) broad inclusion criteria; (3) patient-centered outcomes;
(4) conducted in established community facilities rather
than a referral or university center; (5) commonly available
Fig. 1 Our model developed for IDEA and used for we-can indicating the pathways by which intensive weight loss and exercise can decrease
joint loads and inflammation leading to decreased pain and improved mobility and health related quality of life
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ment; (6) non-physicians trained by our physicians to
perform a knee exam based on American College of
Rheumatology (ACR) clinical criteria; and (7) diverse means
of communication with participants (e.g., phone, email,
study website, Facebook, text messages). Our experience
with ADAPT [9] and IDEA [10] indicates participants need
regular interaction with study staff to achieve significant
weight loss. Hence, the primary efficacy component of our
design is the use of diverse methods of contact by staff who
are not physicians but trained community interventionists
to maintain participant interaction. The pragmatic nature
of many aspects of this trial combined with cost effective
methods of staff-patient communication is more likely to
improve health care that can be generalized and applied in
varied community settings [24].
Methods/Design
Trial organization
The intervention is delivered in communities across North
Carolina including 3 sites in Forsyth County, 2 sites in
Johnston County, and 1 site in Haywood County. The Co-
ordinating Center at Wake Forest University and Wake
Forest Health Sciences in Forsyth County consists of the
Administrative and Data Management Groups that
oversees day-to-day operations, including recruitment,
randomization, data uploads to a central, secured web site,
training sessions, coordinating central resources, reporting
to the Data Safety and Monitoring Board (DSMB), and
collaborating on manuscripts describing trial results
(Fig. 2). The Executive Committee (Principal Investigators
(PIs), site PIs, ad hoc member), with input from the co-investigators, is responsible for major policy decisions gov-
erning trial conduct. Other standing committees include:
a Community Advisory Board that consists of a physician
and patient advocate from each county; Recruitment; Nu-
trition and Exercise Intervention; Nutrition and Health
Attention Control; Adherence and Retention; Safety;
Cost-Effectiveness; Intellectual Property; Ancillary Studies;
and Publications and Presentations.
Research design and methods
Study design
we-can is a Phase III, two arm parallel, pragmatic, assessor-
blinded, community-based trial examining the effects of an
intensive diet-induced weight-loss and exercise intervention
under real-world conditions. It focuses on outcomes that
matter to patients, such as reduced pain (primary outcome)
and improved function, mobility, and health-related quality
of life. It uses broad inclusion criteria, community facilities,
and community exercise leaders and nutrition advisors to
deliver interventions. Strategies to maintain or improve ad-
herence are based in social cognitive theory and are tailored
to real-world delivery.
Study sample
Participants will include 820 ambulatory, community-
dwelling, overweight and obese (BMI ≥ 27 kg/m2) men and
women who meet the ACR clinical criteria for knee OA of
age ≥ 50 years, knee pain on most days of the week, plus at
least 2 of the following: stiffness < 30 min/day; crepitus;
bony tenderness; bony enlargement; no palpable warmth
[25]. With few exclusion criteria (Table 1), participants
with self-reported disability due to knee OA are
Fig. 2 we-can organizational structure
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+ E) or nutrition and health attention control (N + H)
groups, regardless of anticipated risk, past compli-
ance, or comorbidities. All participants may maintain
their regular medications including analgesics. If pain
decreases, they may reduce them with their physi-
cian’s consent. Medications are recorded at baseline,
6-, 12-, and 18-month follow-up visits. The study
protocol was reviewed and approved by the Human
Subjects Committees of Wake Forest Health Sciences
(Human protocol: IRB33618) and The University of
North Carolina at Chapel Hill (Human Protocol:
IRB15-1427) and is in compliance with the terms and
conditions set forth in the Helsinki Declaration.Table 1 Exclusion criteria
Criteria Exclusion
Significant co-morbid disease that would
pose a safety threat or impair ability to
participate; low BMI; no knee OA
Symptomatic or severe coron
walk without assistive device
BMI < 27.0 kg/m2, does not m
knee OA
Ability and willingness to modify dietary or
exercise behaviors
Unwillingness or inability to c
activity habits due to environ
English
Ability to finish or to comply with the
18-month study
Planning to leave area ≥ 2 m
18 months
Significant cognitive impairment Montreal Cognitive Assessme
Transportation Unable to provide own trans
intervention siteRandomization
Each eligible participant is randomized to one of the
two arms of the clinical trial (D + E or N +H) according
to a variable block-length algorithm that is controlled by
the Data Management Group. Randomization is stratified
by intervention site (i.e., Forsyth, Haywood, Johnston
counties) to ensure balance for the two interventions with
respect to each site’s population characteristics (e.g.,
residential, socioeconomic). Within each county, par-
ticipants are also stratified based on BMI (27.0-34.9,
≥ 35.0 kg/m2) and gender to ensure balance across
these factors. Randomization uses a web-based sys-
tem that is part of the study data management
system.Method
ary artery disease; unable to
; blindness; type 1 diabetes;
eet ACR clinical criteria for
Medical history; knee exam using ACR
clinical criteria and performed by
research staff trained by our MDs
hange eating and physical
ment; cannot speak and read
Questionnaire, assessment by
interventionists
onths during the next Questionnaire
nt (MOCA) Medical history, MOCA
portation to and from the Questionnaire
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Table 2 describes each community intervention site.
Johnston County is non-metropolitan with small cities
and rural areas; Forsyth County is metropolitan, with
the city of Winston-Salem and surrounding suburbs;
Haywood County is non-metropolitan with rural and
small city areas. To maintain assessor blinding, each
county has a site to collect participant outcome data that
is separate from the intervention sites.
Interventions
The goal of the D + E intervention is a loss of at least
10% of baseline body weight as recommended by the
National Institutes of Health [26] for overweight and
obese adults and is consistent with our results in IDEA
in which an 11.4% weight loss combined with exercise
reduced knee pain by 51% [27]. The N +H attention
control group, modeled on similar groups in our previ-
ous studies, provides attention, social interaction, and
nutrition and health education [28, 29].
Intensive diet-induced weight loss
The dietary plan is characterized by frequency of con-
tacts, methods to induce caloric restriction, and behav-
ioral strategies. For the first 6 months, the plan is based
on an energy-restricted diet using 1 to 2 partial meal
replacements (Lean Shakes, GNC®) per day provided by
the study with the option to incorporate 1 meal replace-
ment per day during months 7–18. The plan is individu-
alized and based on the program used in IDEA [30].
Based on IDEA, most participants will reach their
weight-loss goal after 9 months. Once it is achieved, they
may self-select to begin weight maintenance or continue
to lose weight using safe, healthy nutrition practices,
provided the participant is motivated to continue losing
weight and has not reached a level associated with pos-
sible health hazards; i.e. > 20% body weight loss at
6 months or >30% at 12 months [31, 32].Table 2 Description of intervention sites by county
County Site Name Description
Forsyth
population 361,220
859 persons/mi2
Healthy Exercise
Lifestyle Programs
Community, universi
Smiley Fitness Private
St. Peter’s World
Outreach Center
Church
Johnston
population 177,967
213 persons/mi2
Johnston Health Care
Medical Mall
Facility within Medic
affiliated with Hospit
Clayton Community Center Parks/Rec Center
Haywood
population 59,183
106 persons/mi2
MedWest Fitness Center Hospital Fitness CenInitial diet plans ensure an energy-intake deficit of
800–1000 kcals/day from the estimated energy expend-
iture (predicted resting metabolism calculated using the
Owen equation [33] x 1.2 activity factor). The exercise
program should expend an average of 200 kcals/day, for
a total imbalance of at least 1,000 kcals/day. The lowest
intake will be 1,100 kcals for women and 1,200 kcals for
men. The distribution goal will be 15–20% protein with
at least 1.2 g protein/kg ideal body weight; <30% fat;
<10% saturated fatty acids; and 45–60% carbohydrates.
These levels are consistent with the Dietary Reference
Intakes for Energy and Macronutrients and successful
weight-loss programs [34]. The amount of protein is
based on recent evidence showing a greater need for
older adults to support good health [35]. The NIH Diet
History Questionnaire is used to assess dietary intake
[36, 37].
There is flexibility in the intervention that permits par-
ticipants to utilize other forms of healthy, low-calorie
meal replacements or pre-portioned meals to replace the
Lean Shakes. For months 7–18, participants consume
meals with healthy foods that follow a recommended
diet plan with an option to incorporate 1 meal replace-
ment per day. Meals are targeted to contain 400–600
kcals and low in fat and sugars and high in vegetables,
fruits, and whole grains. Snacks (~100-120 kcals) may
include a nutrition bar, fruit, or vegetable. Daily energy
intake is adjusted to the rate of weight change with a
goal of 1 kg lost per wk. Each participant is encouraged
to take a daily multivitamin/mineral supplement con-
taining up to 100% of the Dietary Reference Intake per
nutrient. Intervention staff assists in developing meal
plans to provide the prescribed macronutrient-balanced
energy intake.
The intervention staff conducts group and individual
sessions throughout the 18 months (Table 3). Content
emphasizes nutrition and behavioral strategies to attain
the weight-loss goal. At the outset, participants selectSize (sq.ft) Exercise Nutrition
ty setting 20,000 track, aerobic equipment
strength equipment
2 classrooms
2,200 aerobic, strength equip. 1 classroom
73,000 track, strength equipment. 2 classrooms
with kitchen
al Mall
al
197,000 Track, strength equipment 1 classrooms
34,000 Track, aerobic equipment
strength equipment
2 classrooms
ter 54,000 Track, aerobic equipment
strength equipment
2 classrooms
Table 3 Summary of diet-induced weight loss plan and number of planned contacts
Months Weight loss plan Meal Replacements
or equivalent per day (N)
Contacts per month (N)
Total Individual Group
0-6 Energy restriction 800–1000 kcals/day 1-2 4 2a 2
7-12 Either continued energy restriction or weight maintenance
once 10% weight loss reached
0-1 2 1a 1
13-18 Either continued energy restriction or weight maintenance
once 10% weight loss reached
0-1 1 1a none
aIndividual contacts will alternate between face-to-face and a method preferred by the participant (i.e., phone, email, text, etc.)
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website, Facebook, text messages), and information is
distributed accordingly. Individual sessions alternate be-
tween face-to-face and other modes; group sessions are
face-to-face.Alert values
Weight is monitored by the interventionists at each
face-to-face meeting. A >20% loss after 6 months or
>30% after 12 months triggers a safety alert. This infor-
mation is shared promptly with the site medical director
and the Nutrition and Exercise Committee who will de-
termine the next course of action. This information is
reported to the Data and Safety Monitoring Board.
Acute adverse effects are rare in a planned weight-loss
strategy such as we-can, even in older adults. In partici-
pants who experience a serious adverse event, the med-
ical director and the participant’s primary care physician
consult to determine the possibility of continued study
participation.Exercise
The exercise component includes 60-min sessions 3 days
per week for 18 months at one of the designated commu-
nity facilities. The prescribed exercise program consists of
aerobic (15 min), resistance-training (20 min), a second
aerobic (15 min), and cool-down (10 min) phases.
Strength training is particularly relevant to offset any loss
of muscle and bone mass resulting from weight loss. In
addition to the 3 scheduled days, participants are encour-
aged to exercise most other days of the week on their
own. Our protocol is consistent with the American Col-
lege of Sports Medicine (ACSM) guidelines for exercise
for older adults [38]. Monthly exercise logs are used to
monitor progress. Prior to planned absences (e.g., vaca-
tions, caregiver duties) participants receive exercise logs
and personal instruction on substituting home-based exer-
cises to perform while away.
Walking is the primary mode of aerobic training. A tar-
get heart rate range will be calculated as 40–60% of the
heart rate reserve using the Karvonen formula below [39].
The range of 40–60% (i.e., fractional intensity) meets the
ACSM definition of moderate intensity exercise.Target Heart Rate Range ¼ fractional intensityð Þ
 HRmax  HRrestð Þ
þ HRrest
Where HRmax ¼ age−predicted maximum heart rate;
using 208 0:7 ageð Þ
HRrest ¼ resting heart rate
The goal of the strength training is to improve mobil-
ity and balance and attenuate loss of muscle and bone
mass. Resistance exercises include hip abduction/adduc-
tion, leg extension, leg curl, leg press, and heel raise/calf
press. Depending on the resources available at each
community facility, machines, Thera-bands™, free
weights, or the participants’ own body weight are used.
Two sets of 12 repetitions of each exercise are per-
formed with a 1–1.5 min rest between sets. Home exer-
cise serves as a backup for days when facility based
participation is not possible; participants are provided
Thera-bands™ and a manual to continue the same regi-
men as in the facility.
Nutrition and health group
One half of the participants (N = 410) are randomized to
the Nutrition and Health attention control group, mod-
eled after our FAST [40], ADAPT [9], and START [28]
control groups. It provides attention, social interaction,
and evidence-based nutrition and health education deliv-
ered in 1-h, face-to-face group meetings during months
1, 3, 6, 9, and 15, and via informational packets and
webinars during alternate months. The sessions are
interactive and provide useful information on such
topics as protein and dairy, food labels, organic and
non-organic foods, holiday eating, and stress manage-
ment. In addition, N +H group members receive 100
USD for completing their testing visits; 25 USD at
6 month testing and 75 USD at 18 month testing. The
face-to-face meetings feature a community health pro-
fessional, a member of the Community Advisory Board,
or a we-can investigator.
Techniques to improve adherence and retention
we-can’s design evolved from Social Cognitive Theory
(SCT), group dynamics, and our experience with weight
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ior is learned through on-going interactions among the
person, environment, and the behavior; behavior change is
complex and people don’t simply react to the environ-
ment. For example, nutrition practices (behavior) in over-
weight and obese older adults with knee OA may be
affected by the amount of pain experienced (person) and
by interactions with interventionists in the community set-
ting (environment). The study behavioral psychologist
trains we-can community interventionists in standardized
and validated behavioral techniques based on a SCT
framework to enhance adherence. They include regular
contact using diverse methods; positive feedback; estab-
lishing personal commitment to the project; promoting a
sense of community via study logo, cards, and newsletters;
and developing self-efficacy, realistic outcome expecta-
tions, and self-regulatory skills. The importance of regular
attendance is emphasized, and data reviewed regularly to
identify those who need additional reminders and strat-
egies from the toolbox.
Our toolbox approach tailors the intervention to each
participant. When a problem or barrier to participation is
identified, a strategy is tested for a specific period of time
to overcome that problem. If the problem is resolved, the
strategy is continued until behavior change is consistent.
If not, a new strategy is selected and tested for a specific
period. For example, if a participant develops a caregiver
conflict with their scheduled group exercise session, an al-
ternate time is identified to improve attendance; if that
new time still doesn’t work then options to exercise at
home are provided. Communication is scheduled regularly
via their preferred mode of contact to discuss progress
and home logs are monitored over time to ensure that this
new strategy is successful. Some of these strategies are
used in groups, while others require one-on-one inter-
action via the participant’s preferred mode of contact. The
Adherence and Retention Committee reviews adherence
rates at regular intervals; discussions focus on site-specific
adherence rates, barriers to participation, and strategies to
promote adherence.
Training study personnel
Coordinating Center personnel provide on-site training
for the community interventionists during the 9-month
planning period (and during the course of the trial for
newly hired interventionists) and tailor the instruction to
the local facilities. For example, some exercise facilities
have indoor tracks conducive to walking, while others
with less space use treadmills, elliptical trainers, stationary
bikes, or low-impact aerobic dance. Some facilities have a
full kitchen for nutrition classes, while others have no kit-
chen facilities in meeting locations. Tailoring the interven-
tion to each facility and employing and training people
from the local community supports our pragmatic studydesign. Following the initial training sessions, the Coord-
inating Center’s interventionist team monitors fidelity and
the progress of each site via bi-weekly WebEx meetings
with our psychologist, examining adherence rates, barriers
to participation, noncompliant participants, and strategies
that have proved successful. These core values are consist-
ent, effective processes for translating knowledge into
practice [41].
Protocol deviations
Study staff reports all protocol deviations on the study web-
site. Protocol deviations that do not constitute an unantici-
pated problem are submitted to the Safety Committee on a
monthly basis for quarterly review by the Coordinating
Center. Any protocol deviation that results in an unantici-
pated problem and impacts participant safety is reported to
the Safety Committee within 24 h and to the Institutional
Review Board (IRB) and National Institute of Arthritis and
Musculoskeletal and Skin Disease (NIAMS) via KAI
(NIAMS subcontractor) within 48 h of the event. KAI staff
distribute these reports to the DSMB.
Adverse Event (AE) collection and reporting
Participants are queried monthly regarding AEs and en-
couraged to report AEs to their interventionist soon after
they occur. These include any new events not present dur-
ing the pre-intervention period or events that were
present during the pre-intervention period that have in-
creased in severity. Some delayed onset muscle soreness
(DOMS) is expected after training sessions; excessive
DOMS could be reported as an AE, depending on sever-
ity. SAEs are reported to the site PI and site physician
within 24 h of notification by the participant. Non-serious
adverse events (related and unrelated to the study) are re-
ported to the site PI and site physician within 7 days of
notification of the event; the site PI and study physician
will report serious adverse events (SAE) to the Safety
Committee within 24 h and to NIAMS via KAI within
48 h of the initial report (Table 4).
Trial conduct
Recruitment
Recruitment goals for each county were based on previ-
ous recruitment success and population density; Forsyth,
Johnston, and Haywood Counties’ recruitment goals are
450, 220, and 150, respectively (total = 820). With fewer
exclusion criteria than in our previous trials, we conser-
vatively estimate an average yield of 15%. A web-based
data tracking system monitors recruitment strategies in
each county.
We use overlapping recruitment strategies and a moni-
toring system that provides feedback regarding the effect-
iveness and cost of each. Forsyth County uses mailings,
local newspaper ads, and Wake ONE, the Wake Forest
Table 4 Reporting of serious adverse events
Type of Event Reporting Requirements Reporting Requirements Reporting Requirements
Initial Report Clinical Site Safety Committee
Serious Adverse
Events (SAE)
Reported to Site
PI/Physician immediately
Within 24 h of initial receipt of the
information Clinical Site will report
to Safety Committee
Within 24 h of initial receipt of the information Safety
Committee will report to NIAMS (48 h from initial report)
Non serious
Adverse Events (AE)
Reported to Site
PI/Physician within 7 days
Reported in monthly
correspondence to Safety Committee
Reported in Bi-annual correspondence to NIAMS
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with local aging service networks and access to senior cen-
ters, senior high-rise residential sites, churches, and a large
database of older adults who have signed consent to be
contacted about participating in future clinical trials. The
University of North Carolina Chapel Hill has a similar rela-
tionship with Johnston County and has ready access to a
large segment of the population, many who have signed
consent to be contacted for future studies. The most suc-
cessful recruitment methods for clinical trials in the county
have been through the Johnston County Health System
(which is part of the UNC Health System and patient data-
base), primary care offices, local newspapers, radio/TV
shows, the Seniors Guide, a Parks and Recreation Brochure,
the newsletter for the Town of Clayton, and the Clayton
Community Center. Methods of recruitment in Haywood
include community talks, physician practices, local news-
paper articles and/or advertisements, local orthopedic
groups, and the Haywood Health and Fitness Center.
The three recruitment coordinators plan strategies and
activities for each clinical site. Our experience indicates
that monitoring the recruitment process continually is
necessary to achieve study goals. At bi-weekly meetings,
the Recruitment Committee reviews all recruitment ac-
tivities, plans new ones, and monitors the number of
phone contacts, screening visits (SV1), and participants
randomized. We estimate yields as the project pro-
gresses to determine whether our strategies should be
intensified or altered. Specific strategies aim to maximize
the number of African-Americans who qualify for, and
are enrolled in the study. Haywood and Johnston coun-
ties contribute heavily to our rural population, another
underrepresented cohort in clinical trials.
Timeline
Recruitment for each of 10 waves takes approximately
3 months with an average of 82 participants/wave across all
three intervention sites; an average of 45, 22, and 15 partici-
pants are randomized per wave for Forsyth, Johnston, and
Haywood counties respectively (Table 5).
Measurements
Screening and follow-up visits
The Western Ontario McMasters Universities Osteo-
arthritis Index (WOMAC) pain (primary outcome) andfunction (secondary outcome) subscales are detailed
below [42, 43]. Other secondary measures including the
appropriate citations that detail the metrics for each test
instrument are listed in Table 6. Questionnaires and per-
formance measures are completed at baseline, 6 month
follow-up (FU6), FU12, and FU18. Participant eligibility
and screening flow chart are shown in Fig. 3.Screening
Self-reported pain (primary outcome) and physical func-
tion are measured using the Likert version of the
WOMAC [43]. The pain index (included as a subscale of
the KOOS questionnaire [44]) assesses participants’ pain
on a scale ranging from 0 (none) to 4 (extreme). The pain
subscale consists of 5 items and total scores can range
from 0 to 20, with higher scores indicating greater pain.
This instrument is recommended by the Osteoarthritis Re-
search Society International as the health status measure
of choice for older adults with knee OA. It has been vali-
dated for use in orthopaedic and pharmacologic interven-
tions. The pain subscale is also used as a screening tool
during SV1 (pain must be ≥ 1 on WOMAC pain subscale).
It is also administered to the eligible participants at each
scheduled follow-up visit.
For physical function, the Likert version asks partici-
pants to indicate on the same scale from 0 (none) to 4
(extreme) the degree of difficulty experienced perform-
ing activities of daily living in the last 48 h due to knee
pain. Individual scores for the 17 items are totaled to
generate a summary score that can range from 0 to 68,
with higher scores indicating poorer function.Statistical considerations
Data management
The Data Management Group of the Coordinating Center
has primary responsibility for randomization, quality con-
trol, and analyses of data generated by the clinical centers.
Primary outcomes and nutrient intake data are collected
on hard-copy forms at each site and transferred to an elec-
tronic database, while secondary outcomes are collected
either electronically or on paper. Our web-based manage-
ment system assures integrity and validity. Dynamic re-
ports and periodic statistical analyses monitor quality. A
participant-based inventory system tracks recruitment,
Table 5 Study time line with milestones
Planning Months1-6 1st subject enrolled in intervention 25% enrolled 50% enrolled 75% enrolled 100% enrolled
Wave 1 Wave 2 Wave 3 Wave 4 Wave 5 Wave 6 Wave 7 Wave 8 Wave 9 Wave 10
Recruitment months 7-9 10-12 13-15 16-18 19-21 22-24 25-27 28-30 31-33 34-36
Intervention 10-27 13-30 16-33 19-36 22-39 25-42 28-45 31-48 34-51 37-54
N 82 164 246 328 410 492 574 656 738 820
Analysis and Final Report: Months 54-60
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exit, close-out, and lock-down of final datasets.
Statistical analyses
All primary analyses are based on intention-to-treat prin-
ciples in full accordance with CONSORT guidelines [45].
Primary analysis
The primary hypothesis of less WOMAC pain in the
D + E group at FU18 compared to the N +H attention
control group is tested based on a two-tailed significance
level of 0.05 using contrast statements from a repeated
measures mixed linear model with time (6, 18 months),
randomization arm (D + E vs N +H), and the interaction,
which adjusts the means at each time point for potential
missing data bias. Intervention-effect estimates are further
adjusted for baseline pain values, BMI, county, and gen-
der; analysis matches the design, so the variance estimate
is not biased.
Secondary aim 2
Repeated measures mixed linear models similar to those
for Aim 1 are used to analyze WOMAC function, 6-min
walk, and SF-36 physical subscale. Each outcome is
modeled separately, and 18-month effectiveness tested
based on a two-tailed significance level of 0.05.
Sample size and power calculations
Primary outcome
Based on ADAPT, the control group is expected to reduce
pain by approximately 10%; therefore, a 15% between-
group difference would require a 25% within-group im-
provement from baseline, exceeding a minimally clinically
important improvement (MCII) of 20% [9, 46]. A total
sample of 820 (410/group) will provide 94% statistical
power to detect differences ≥15% in pain at the 2-sided
0.05 significance level with 80% retention (2-sample t-test,
Nquery Advisor). In IDEA, the intent-to-treat analysis re-
vealed a 51% reduction in pain in the D + E group, which
suggests these assumptions are conservative.
Secondary outcomes
Our sample size can detect a moderate effect size of 0.234
at 85% power with relevant detectable differences. How-
ever, all estimates from IDEA and ADAPT were collectedunder rigorously controlled conditions; therefore, the esti-
mates for the pragmatic trial are conservative. We assume
a total baseline sample size of N = 820, 80% retention at
18 months, and a 0.05 level of significance for all tests.
Economic evaluation
To establish the effectiveness of the pragmatic weight
loss and exercise intervention appropriate data are col-
lected to address the question of cost-effectiveness. In
addition to formal cost-effectiveness analysis, a budget
impact analysis will quantify the financial consequences
of adopting the program by various payer models, in-
cluding insurance organizations, healthcare systems, and
government, given real-life resource constraints. The re-
sults can be used for budget planning and changes in
health insurance premiums.
Data on resource use are collected at 6-month intervals.
Direct medical costs include costs of inpatient stays and
procedures (including knee surgery); outpatient physician,
physical therapy, and emergency room visits; laboratory
studies, medical devices, and medications, prescribed and
non-prescribed. Costs of the intervention includes the
meal replacements, monitoring, the wages of intervention
and control personnel over the period of the intervention,
and any facility rental costs needed to deliver the interven-
tion. Direct nonmedical costs and indirect costs include
transportation to intervention centers and other costs to
the participant and family to ensure he or she can take
part in all we-can activities.
We also gather data on indirect costs of lost wages for
employed participants (e.g., equivalent to 31% of lost
wages in IDEA). Data on time costs (productivity losses)
are collected and included in sensitivity analyses. The
primary analysis is conducted without indirect costs per
recommendations of the Panel on Cost-Effectiveness in
Health and Medicine [47, 48]. Quality-adjusted life years
(QALYs) is our measure of effectiveness [49, 50]. In all
analyses, a 3% per year discounting is applied to both
costs and effectiveness [48]. The cost-effectiveness ana-
lysis is performed for the trial’s duration and remaining
lifetime of the participants.
Discussion
Exercise and weight loss have level 1 evidence of efficacy
[6] for pain relief and the combination is most efficacious
Table 6 Measurements with screening and follow-up visit schedule
Measurements PSV SV1 FU6 FU12 FU18 Explanation
Questionnaires
Informed Consent x
Eligibility Questionnaire x To determine eligibility
Medical History xc x x x x For eligibility and to document changes in health
Risk Stratification xc x Used to screen for cardiovascular risk [54]
Comorbidities Questionnaire x x x x [55]
Randomization x
WOMAC x x x x Pain is primary outcome [42]
KOOS x x x x Pain, symptoms, ADL, sport, recreation, knee QOL [56]
ICOAP x x x x Intermittent and constant osteoarthritis pain, 2 sleep questions [57]
Cost Effectiveness x x x x
PASE scale x x x x Physical Activity Scale for the Elderly [58]
MOCA x x Montreal Cognitive Assessment [59, 60]
CES-D x x x x The Center for Epidemiologic Studies Depression Scale [61]
EuroQol Quality of Life(EQ5D) x x x x Quality of life measure [62]
Work History Resource x x x x Visits to clinicians, tests, medications, injections, surgery, alternative
therapies
Work Productivity and Activity Impairment
Index
x x x x Assesses absenteeism and presenteeism [63]
DHQ II x x x x NIH Diet History Questionnaire [36, 37]
SF-36 x x x x Health related quality of life [physical, mental] [64]
Self-Efficacy-Adherence x x x x Belief can exercise over time [65]
Perceived Stress (PSS) x x x x The degree to which people perceive their lives as stressful [66]
Pain Catastrophizing Scale (PCS) x x x x Catastrophizing [rumination, magnification, and helplessness] [67, 68]
Healthy Literacy x x x x Functional health literacy [69]
Walking Efficacy for Duration x x x x Confidence in walking for different durations [65]
Gait Efficacy x x x x Confidence in completing gait related tasks [65]
Weight Efficacy Lifestyle Questionnaire (WEL) x x x x Self-Efficacy for weight management [70]
Positive and Negative Affect Scale (PANAS) x x x x Positive and Negative Affect [71]
Demographics x
Medication form x x x x Atherosclerosis Risk in Communities form [72]
Satisfaction With Life Scale x x x x Quality of life [73]
Physical Performance Tests/Knee Exam
Height and weight x x To determine BMI
Adverse Events x x x x Also collected as they occur
Knee exam x To determine eligibility
Pain Severity x x x To determine MCID [74]
6 min walk x x x x Measure of mobility [75]
Expanded Short Physical Performance Battery
(SPPB)
x x x x Gait speed, sit to stand, balance tests; predicts disability [76]
Functional Leg Strength x x x x Sit to stand test, part of SPPB
Blood Pressure x x x x Overall health measure
GAITRite gait analysis x x x x Temporospatial gait variables
Stair climb x x x x Timed Stair ascent and descent [77]
xc brief screen by self-report, PSV Prescreening Visit, SV screening visit, FU follow-up 6, 12, 18 months after screening visit, MCID minimally clinically
important difference
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Fig. 3 Participant eligibility and screening flow chart. BMI = body mass index; CHD = cardiovascular heart disease; ACR = American College
of Rheumatology
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to community programs, either because they don’t exist
or because non-pharmacologic alternatives are not part of
the treatment plan [2]. Intensive weight loss combined
with exercise reduces abnormal stress by decreasing knee
joint loads and reduces abnormal physiology by lowering
inflammation [10]. This results in less pain and less dis-
ability. Losing 10% of baseline body weight is necessary
for a moderate to large clinical effect. We found a dose
response to weight change with pain and function, inde-
pendent of group assignment; IDEA participants who lost
more than 10% of baseline body weight had greater reduc-
tions in pain and improvements in function than partici-
pants who lost between 5 and 10% and less than 5% of
baseline body weight [10]. Hence, our minimum weight
loss goal for the we-can diet and exercise group is 10% of
baseline body weight.
Losing weight and maintaining weight loss are both
difficult and often unsuccessful. Biological changes fightattempts to lose weight; the body acts in starvation mode
increasing feelings of hunger, it suppresses satiety, slows
metabolic rate, and attempts to defend higher body
weights [51]. We exceeded our mean weight loss goal of
10% in IDEA, in part because participants received regular
attention. A similar pragmatic, community based trial of
diet and exercise for obese women free of knee OA found
that limited patient contact (≤4 h/year) during the 2.5 year
intervention period resulted in less than 20% of the D + E
group achieving their weight loss goal of ≥ 5 kg or ≥ 5% of
baseline body weight (mean weight loss < 1 kg) [52, 53].
Indeed, a possible consequence of a pragmatic approach
with little or no participant contact is low adherence. The
challenge in we-can is to maintain the regular patient
contact utilized in IDEA in a less structured, community-
based environment. The use of multiple communication
techniques with participants is critical in achieving com-
pliance and retention rates that approach those achieved
in IDEA. These include, but are not limited to, phone
Messier et al. BMC Musculoskeletal Disorders  (2017) 18:91 Page 12 of 14calls, text messages, email, Facebook, LinkedIn, Skype,
Twitter, and YouTube. Participants will select their pre-
ferred method of communication.
Maintaining intervention fidelity is critical. Fostering
close relationships with the community centers that
serve as intervention sites is important in maintaining
an open line of communication. Site interventionists
maintain personal relationships with participants both
face to face and electronically. The Coordinating Center
staff monitors the quality of the intervention being deliv-
ered with periodic face-to-face observations, biweekly
Adherence and Retention Committee meetings, and
monthly Nutrition and Exercise Committee meetings. In-
cluding underserved rural communities such as Haywood
and Johnston counties in knee OA clinical trials is unique;
however, recruitment and retention may be difficult as
communication and transportation concerns are compli-
cated by lower socioeconomic conditions and a less densely
populated recruitment base. The recruitment goals for
Johnston and Haywood counties have been adjusted to re-
flect these anticipated impediments.
To meet the chronic disease burden the Centers for Dis-
ease Control and Prevention launched several strategic ini-
tiatives of which one is to establish community-based
programs to support healthy behaviors [22]. Indeed, the
physician’s dilemma is the lack of practical means to im-
plement and sustain a diet and exercise program in a
community-based environment. we-can is designed to test
the effectiveness of a community program that will serve
as a blueprint and exemplar for clinicians and public
health officials in urban and rural communities to imple-
ment a weight loss and exercise program designed to re-
duce knee pain and improve other clinical outcomes in
overweight and obese adults with knee OA. We envision a
national implementation of this systematic program that
will serve as a model for healthcare professionals on
implementing a platform that is accessible to consumers
and clinicians, and is of value to insurers because it can be
sustained long-term and at a reasonable cost.Acknowledgements
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